<i>In vitro</i> and <i>in vivo</i> study of inhibitory potentials of α-glucosidase and acetylcholinesterase and biochemical profiling of <i>M. charantia</i> in alloxan-induced diabetic rat models.

Abstract

<i>M. charantia</i> can be recommended as a therapeutic adjunct for diabetic patients as it can provide favorable remedial action in the context of the diabetes continuum of metabolic syndrome.